BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.500
-0.100 (-6.25%)
Jun 4, 2026, 11:50 AM IDT
BioLineRx Employees
As of December 31, 2025, BioLineRx had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 4 or -14.29% compared to the previous year.
Employees
24
Change (1Y)
-4
Growth (1Y)
-14.29%
Revenue / Employee
201.21K ILS
Profits / Employee
-1.13M ILS
Market Cap
41.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -4 | -14.29% | 20 | 4 |
| Dec 31, 2024 | 28 | -51 | -64.56% | 24 | 4 |
| Dec 31, 2023 | 79 | 30 | 61.22% | 79 | 0 |
| Dec 31, 2022 | 49 | 11 | 28.95% | 49 | 0 |
| Dec 31, 2021 | 38 | 0 | - | 38 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Bonus BioGroup | 42 |
| Matricelf | 15 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| Geffen Residence & Renewal | 6 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
BioLineRx News
- 5 days ago - BioLineRx (BLRX) Q1 2026 Earnings Transcript - The Motley Fool
- 7 days ago - BLRX Achieves Key Milestones in Clinical Development and Revenue Growth - GuruFocus
- 7 days ago - BioLineRx Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - BioLineRx Earnings release: Q1 2026 - Filings
- 7 days ago - BioLineRx reports Q1 EPS 0c vs. (0c) last year - TheFly
- 7 days ago - BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 12 days ago - BioLineRx to Present GLIX1 Preclinical Data at ASCO 2026 - GuruFocus
- 12 days ago - BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - PRNewsWire